Civitas Resources, Inc. (CIVI) analyst actions

Rating and price-target actions on CIVI in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CIVI overview →

7 measured CIVI analyst action events.

DateHeadlineEvent5-minTo close
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Civitas Resources, Inc. (CIVI) And Encourages Shareholders to Reach OutPress release+0.09%—
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Civitas Resources, Inc. (CIVI) And Encourages Stockholders to Reach OutPress release+0.50%+0.14%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Civitas Resources, Inc. (CIVI) And Encourages Shareholders to Reach OutPress release-1.32%-0.61%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Civitas Resources, Inc. (CIVI) And Encourages Stockholders to Reach OutPress release-0.35%+1.04%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Civitas Resources, Inc. (CIVI) And Encourages Stockholders to Reach OutPress release+0.10%-1.54%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Civitas Resources, Inc. (CIVI) And Encourages Shareholders to Reach OutPress release+0.13%-3.31%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Civitas Resources, Inc. (CIVI) And Encourages Stockholders to Reach OutPress release-0.10%-5.15%
Get an email when CIVI moves on news →
Keep exploring

More CIVI: earnings → · SEC filings → · CIVI overview →

Other Healthcare names and their analyst actions

TickerEventsMedian 30-min% positive
Arena Pharmaceuticals, Inc. (ARNA)1,0520.00%47%
Global Blood Therapeutics, Inc. (GBT)1,048+0.13%55%
VIVUS (VVUS)1,044-0.36%41%
GraniteShares YieldBOOST CRCL ETF (CRY)1,0380.00%49%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.